1. Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development: Part 3—Introduction to Pharmacodynamic Modeling Methods. (2nd January 2014) Authors: Upton, RN; Mould, DR Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling Methods. (17th April 2013) Authors: Mould, DR; Upton, RN Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 2:Number 4(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Decision Support Tools: The Evolution of a Revolution. Issue 4 (15th February 2016) Authors: Mould, DR; D'Haens, G; Upton, RN Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 4(2016:Apr.) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations. (21st January 2015) Authors: Mould, DR; Walz, A‐C; Lave, T; Gibbs, JP; Frame, B Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 1(2015:Jan.) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics. (10th February 2017) Authors: Nguyen, THT; Mouksassi, M‐S; Holford, N; Al‐Huniti, N; Freedman, I; Hooker, AC; John, J; Karlsson, MO; Mould, DR; Pérez Ruixo, JJ; Plan, EL; Savic, R; van Hasselt, JGC; Weber, B; Zhou, C; Comets, E; Mentré, F Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 2(2017) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities. Issue 1 (9th December 2014) Authors: Venkatakrishnan, K; Friberg, LE; Ouellet, D; Mettetal, JT; Stein, A; Trocóniz, IF; Bruno, R; Mehrotra, N; Gobburu, J; Mould, DR Journal: Clinical pharmacology & therapeutics Issue: Volume 97:Issue 1(2015:Jan.) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Role of FcRn in the Pharmacokinetics of Biologics in Patients With Multiple Myeloma. Issue 6 (26th May 2017) Authors: Jacobs, JFM; Mould, DR Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 6(2017) Page Start: 903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Why therapeutic drug monitoring is needed for monoclonal antibodies and how do we implement this?. Issue 4 (15th December 2015) Authors: Mould, DR Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 4(2016:Apr.) Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗